News
New Sementis CEO to Advance Vaccine Technology
September 2023 Biotechnology company Sementis will advance its position at the forefront of vaccine technology with the...
August 2021
Adelaide biotech company Sementis is aiming to raise $10m to accelerate work on its next-generation Covid-19 vaccine, which it hopes to have in production within 18 months.
Digital subscribers to The Australian can read more here.